D-1362-2022 Class II Terminated

Recalled by Amneal Pharmaceuticals Of New York, LLC — Brookhaven, NY

FDA drug recall D-1362-2022 was initiated by Amneal Pharmaceuticals Of New York, LLC on Jul 27, 2022 and is designated Class II. Reason for recall: Failed dissolution specifications. The recall status is terminated (terminated Aug 17, 2023). Affected quantity: 4,309 bottles.

Recall details

Product Type
Drugs
Report Date
Aug 31, 2022
Initiation Date
Jul 27, 2022
Termination Date
Aug 17, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4,309 bottles

Product description

Divalproex Sodium Extended Release Tablets, USP, 250 mg, packaged in 100-count bottle, Rx only, Manufactured by: Amneal Pharmaceuticals, India, Distributed by: Amneal Pharmaceuticals, Bridgewater, NJ, NDC 65162-755-10

Reason for recall

Failed dissolution specifications.

Distribution pattern

USA nationwide

Code information

Lot #: AR210705, Exp 04/2024

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1362-2022
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1362-2022. Report a data issue: hello@regdatalab.com.